ARPO · Categories · Form 4

ARPO - SEC Form 4 insider transactions

Aerpio Pharmaceuticals, Inc. (ARPO) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for ARPO

• 1721d
  SEC Form 4 filed by Delaney Brendan

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1733d
  SEC Form 4 filed by Desai Neil

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1733d
  SEC Form 4 filed by Reeve Emma

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1742d
  SEC Form 4 filed by Hehenberger Karin M.

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1742d
  SEC Form 4 filed by Maroun Richard E

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1743d
  SEC Form 4: Dalal Anupam bought $19,999,990 worth of Common Stock (1,529,402 units at $13.08) (Amendment)

  4/A - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1743d
  SEC Form 4: Castelein Caley bought $3,399,994 worth of Common Stock (259,998 units at $13.08)

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1743d
  SEC Form 4: Dalal Anupam bought $19,999,990 worth of Common Stock (1,529,402 units at $13.08)

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1744d
  SEC Form 4: Aghazadeh Behzad was granted 1,911,752 units of Common Stock

  4 - Aadi Bioscience, Inc. (0001422142) (Issuer)
• 1803d
  SEC Form 4: Dalal Anupam was granted 7,400 units of Common Stock, increasing direct ownership by 77% to 16,959 units

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1803d
  SEC Form 4 filed by Aerpio Pharmaceuticals, Inc.

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1803d
  SEC Form 4: Prelack Steven was granted 12,334 units of Common Stock, increasing direct ownership by 102% to 24,485 units

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1803d
  SEC Form 4: Castelein Caley was granted 7,811 units of Common Stock, increasing direct ownership by 3% to 295,414 units

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1803d
  SEC Form 4: Cohen Cheryl was granted 8,140 units of Common Stock, increasing direct ownership by 101% to 16,160 units

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1813d
  SEC Form 4 filed by Cohen Cheryl

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1893d
  SEC Form 4: Caley Castelein was granted 7,696 units of Common Stock, increasing direct ownership by 3% to 287,603 units

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1893d
  SEC Form 4: Steven Prelack was granted 12,151 units of Common Stock

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1893d
  SEC Form 4: Pravin Dugel was granted 6,237 units of Common Stock

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1893d
  SEC Form 4: Anupam Dalal was granted 7,290 units of Common Stock, increasing direct ownership by 321% to 9,559 units

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1893d
  SEC Form 4: Cheryl Cohen was granted 8,020 units of Common Stock

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1951d
  SEC Form 4 filed by Pravin Dugel

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1951d
  SEC Form 4 filed by Cheryl Cohen

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1951d
  SEC Form 4 filed by Anupam Dalal

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)
• 1951d
  SEC Form 4 filed by Caley Castelein

  4 - Aerpio Pharmaceuticals, Inc. (0001422142) (Issuer)

Other ARPO categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends